When should a permanent feeding jejunostomy be considered?

When to Consider a Permanent Feeding Jejunostomy

A permanent feeding jejunostomy should be considered when long-term enteral nutrition (>6 weeks) is required and gastric feeding is not feasible due to altered foregut anatomy, high aspiration risk, severe gastroparesis, or gastric outlet obstruction. 1

Primary Indications for Permanent Jejunostomy

Long-Term Enteral Nutrition Requirements (>6 weeks)

Percutaneous endoscopic jejunostomy (PEJ) is the preferred access device when long-term home enteral nutrition is required and gastric routes are contraindicated. 1 This recommendation carries a Grade B evidence level with 93% consensus among experts.

Specific Clinical Scenarios

Permanent jejunostomy should be strongly considered in:

• Altered foregut anatomy: Previous gastrectomy, esophagectomy, or other upper GI resections where gastric access is anatomically impossible 2

• High aspiration risk: Patients with severe gastroesophageal reflux, documented aspiration events, or neurological conditions predisposing to aspiration 1, 3

• Severe gastroparesis or gastric outlet stenosis: When gastric emptying disorders prevent adequate nutrition via gastric routes 1

• Gastroduodenal motility disorders: Conditions where gastric feeding is poorly tolerated despite optimization 1

Surgical Context: Intraoperative Placement

In patients with malnutrition or high metabolic risk undergoing major upper GI surgery (esophagectomy, total gastrectomy, pancreatoduodenectomy), intraoperative placement of a feeding jejunostomy should be considered. 4 This carries a Grade B recommendation with 89% consensus.

The rationale is compelling:

• Complication rates for needle catheter jejunostomy (NCJ) range from 1.5-6% when performed by experienced surgeons 4
• Patients undergoing esophagectomy with jejunostomy feeding for 6 weeks showed significantly less weight loss and higher calorie/protein intake at 4-5 weeks and 4 months postoperatively 4
• Particularly valuable for patients requiring adjuvant chemotherapy or radiotherapy, as 75% of patients requiring adjuvant therapy needed enteral nutrition during treatment 5

Critical Caveat for Surgical Jejunostomy

While some authors consider routine jejunostomy placement "redundant" and recommend it only for high-risk patients 4, the evidence supports routine placement in patients with malnutrition, high metabolic risk, or those likely requiring adjuvant therapy, as it's difficult to predict preoperatively who will need prolonged enteral nutrition 5.

Patient Selection Algorithm

Consider Permanent Jejunostomy When:

1. Duration: Enteral nutrition anticipated >6 weeks 1

2. Life expectancy: >1 month (HEN generally not recommended if life expectancy <1 month) 1

3. Gastric route contraindicated due to:

   • Anatomical barriers (prior surgery)
   • Functional barriers (gastroparesis, severe reflux)
   • Safety concerns (recurrent aspiration)

4. Patient factors:

   • Functional GI tract distal to ligament of Treitz
   • Ability to comply with home enteral nutrition
   • Patient/caregiver agreement with therapy 1

Contraindications to Avoid

Absolute contraindications include:

• Active peritonitis
• Uncorrectable coagulopathy
• Ongoing bowel ischemia 2

Relative contraindications:

• Severe functional bowel disturbances
• Gastrointestinal obstruction
• Active GI bleeding
• Severe malabsorption 1

Technical Considerations

Type Selection

• Roux-en-Y jejunostomy: Preferred for younger patients requiring lifelong enteral feeding; lower aspiration risk compared to gastrostomy (35% aspiration rate with gastrostomy vs. minimal with Roux-en-Y) 3, 6, 7

• Stamm jejunostomy: Appropriate for older patients or those with shorter life expectancy 3

• Needle catheter jejunostomy (NCJ): Lowest complication rate (1.5%) when placed intraoperatively during upper GI surgery 4, 8

Risk Factors for Complications

Be aware that certain patient characteristics increase risk:

• Obesity: Risk factor for technical failure 2
• Age >80 years: Associated with higher mortality 2
• Diabetes mellitus: Increased complication risk 2
• Ongoing inflammatory status: Higher mortality risk 2

Quality of Life Considerations

PEJ offers superior quality of life compared to nasogastric tubes with lower tube dislodgement rates and better patient satisfaction, though evidence shows no significant difference in mortality or aspiration pneumonia between PEG and nasogastric feeding 1. The decision should prioritize long-term nutritional adequacy and patient tolerance over short-term convenience.

Common Pitfalls to Avoid

1. Delaying placement until severe malnutrition develops: Consider early in patients with progressive dysphagia or anticipated prolonged inability to meet nutritional needs

2. Assuming all patients tolerate gastric feeding: Up to 54% of post-gastrectomy patients require continued enteral nutrition at discharge due to failure to thrive 5

3. Premature tube removal: Exercise caution removing unused tubes if adjuvant therapy is planned—75% will require nutrition support during treatment 5

4. Inadequate patient selection: Ensure functional bowel distal to placement site and realistic life expectancy to justify the procedure